One can not automatically assume that a failure to show a difference in efficacy implies equally effective treatments. Those who fully read the article will know that the statistical analysis failed to show a difference between the two treatment arms; it does not assert that bevacizumab and ranibizumab are equally effective. The total sample size is insufficient to make a statement regarding which treatment is more effective. This is acknowledged in the article several times, particularly where limitations of the study are discussed.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jan 17, 2017 | Posted by in OPHTHALMOLOGY | Comments Off on Reply

Full access? Get Clinical Tree

Get Clinical Tree app for offline access